glp-1 obesity drug news today september 15 2025 Outlook for in 2026: From Consolidation to Acceleration GLP-1 Agonists: Using Semaglutide, Tirzepatide,

GLP-1 receptor agonists like Semaglutide and Tirzepatide (a newer dual-acting drug) work by activating GLP-1 receptors, thereby amplifying its effects on insulin, appetite suppression, and digestion

Disclaimer: This article is for educational purposes only

The cardiorenal effects of both GLP-1RA and SGLT-2 inhibitors can be summarized as follows: GLP-1RA have moderate benefits on MACE (major cardiovascular events), may reduce all-cause mortality and hospitalization for HF (HHF), and have a robust effect in reducing the incidence of macroalbuminuria [12]

EASY SOURCE OF ANTIOXIDANTS - Glutathione, collagen & vitamin C produced by the liver and involved in many body processes

By inhibiting the proliferation and colonization of harmful bacteria, probiotics foster a healthier microbial equilibrium and reduce susceptibility to infections (190)